ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Faculty Opinions recommendation of Lapatinib plus capecitabine for HER2-positive advanced breast cancer.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.1059703.518676
◽
2007
◽
Author(s):
Daniel Vorobiof
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Advanced Breast
◽
Her2 Positive
Download Full-text
Related Documents
Cited By
References
Pyrotinib in Combination With Nab-paclitaxel in Patients With HER2-positive Advanced Breast Cancer: an Exploratory Study
Case Medical Research
◽
10.31525/ct1-nct03919253
◽
2019
◽
Author(s):
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Exploratory Study
◽
Advanced Breast
◽
Her2 Positive
Download Full-text
Phase II Clinical Study of Pyrotinib Combined With Etoposide to Treat HER2-positive Advanced Breast Cancer
Case Medical Research
◽
10.31525/ct1-nct03923179
◽
2019
◽
Author(s):
Keyword(s):
Breast Cancer
◽
Clinical Study
◽
Advanced Breast Cancer
◽
Phase Ii
◽
Advanced Breast
◽
Her2 Positive
◽
Phase Ii Clinical Study
Download Full-text
Faculty Opinions recommendation of Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.718355395.793494247
◽
2014
◽
Author(s):
Ana Maria Gonzalez-Angulo
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Advanced Breast
◽
Her2 Positive
◽
Phase 3
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
IL-8 secreted by tumor associated macrophages contribute to lapatinib resistance in HER2-positive locally advanced breast cancer via activation of Src/STAT3/ERK1/2-mediated EGFR signaling
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
◽
10.1016/j.bbamcr.2021.118995
◽
2021
◽
pp. 118995
Author(s):
Shaza Ahmed
◽
Hossam Taha Mohamed
◽
Noura El-Husseiny
◽
Manal M. El Mahdy
◽
Gehan Safwat
◽
...
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Locally Advanced Breast Cancer
◽
Locally Advanced
◽
Advanced Breast
◽
Egfr Signaling
◽
Tumor Associated Macrophages
◽
Her2 Positive
Download Full-text
p85 Protein Expression is Associated with Poor Survival in HER2-Positive Patients with Advanced Breast Cancer Treated with Trastuzumab
Pathology & Oncology Research
◽
10.1007/s12253-014-9818-2
◽
2014
◽
Vol 21
(2)
◽
pp. 273-282
◽
Cited By ~ 6
Author(s):
Kitty Pavlakis
◽
Mattheos Bobos
◽
Anna Batistatou
◽
Vassiliki Kotoula
◽
Anastasia G. Eleftheraki
◽
...
Keyword(s):
Breast Cancer
◽
Protein Expression
◽
Advanced Breast Cancer
◽
Advanced Breast
◽
Poor Survival
◽
Her2 Positive
Download Full-text
Lapatinib in combination with capecitabine in the management of ErbB2-positive (HER2-positive) advanced breast cancer
Biologics: Targets and Therapy
◽
10.2147/btt.s1713
◽
2008
◽
pp. 61
Author(s):
Steven Stein
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Advanced Breast
◽
Her2 Positive
Download Full-text
Peripheral cytotoxic T lymphocyte predicts first-line progression free survival in HER2-positive advanced breast cancer
The Breast
◽
10.1016/j.breast.2020.11.006
◽
2021
◽
Vol 55
◽
pp. 7-15
Author(s):
Xiao-Ran Liu
◽
Jian-Jun Yu
◽
Guo-Hong Song
◽
Li-Jun Di
◽
Han-Fang Jiang
◽
...
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
T Lymphocyte
◽
Cytotoxic T Lymphocyte
◽
Progression Free Survival
◽
Advanced Breast
◽
First Line
◽
Her2 Positive
◽
Free Survival
Download Full-text
Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial
The Lancet Oncology
◽
10.1016/s1470-2045(14)70178-0
◽
2014
◽
Vol 15
(7)
◽
pp. 689-699
◽
Cited By ~ 350
Author(s):
Ian E Krop
◽
Sung-Bae Kim
◽
Antonio González-Martín
◽
Patricia M LoRusso
◽
Jean-Marc Ferrero
◽
...
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Advanced Breast
◽
Trastuzumab Emtansine
◽
Her2 Positive
◽
Open Label
◽
Phase 3
◽
Open Label Phase
◽
Versus Treatment
Download Full-text
2127 POSTER Activity of Fulvestrant in patients with HER2-positive advanced breast cancer
European Journal of Cancer Supplements
◽
10.1016/s1359-6349(07)70889-3
◽
2007
◽
Vol 5
(4)
◽
pp. 222
Author(s):
J.F.R. Robertson
◽
G. Steger
◽
P. Neven
◽
S. Barni
◽
B. Kaufman
◽
...
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Advanced Breast
◽
Her2 Positive
Download Full-text
Abstract OT1-1-02: A single-arm phase IIIb study of pertuzumab and trastuzumab with a taxane as first-line therapy for patients with HER2-positive advanced breast cancer (PERUSE)
10.1158/0008-5472.sabcs12-ot1-1-02
◽
2012
◽
Cited By ~ 4
Author(s):
T Bachelot
◽
E Ciruelos
◽
T Peretz-Yablonski
◽
A Schneeweiss
◽
F Puglisi
◽
...
Keyword(s):
Breast Cancer
◽
Advanced Breast Cancer
◽
Advanced Breast
◽
First Line
◽
Her2 Positive
◽
First Line Therapy
◽
Line Therapy
◽
Phase Iiib
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close